Mainstream

Basilea Pharmaceutica Gaap Eps Of Chf5.83, Revenue Of Chf208.5m; Initiates Fy25 Outlook

Basilea Pharmaceutica GAAP EPS of CHF5.83, revenue of CHF208.5M; initiates FY25 outlook

Basilea Pharmaceutica GAAP EPS of CHF5.83, revenue of CHF208.5M; initiates FY25 outlook

Post ContentbpmufRead More

You might also be interested in reading Silicon Valley’s largest start-ups to shun IPOs in 2025.

February 18, 2025
In Mainstream